vraylar

Generic: cariprazine

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vraylar
Generic Name cariprazine
Labeler allergan, inc.
Dosage Form CAPSULE, GELATIN COATED
Routes
ORAL
Active Ingredients

cariprazine .5 mg/1

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 61874-250
Product ID 61874-250_db2154b0-f0c7-403c-95fd-794666e79e30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204370
Listing Expiration 2026-12-31
Marketing Start 2025-12-18

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61874250
Hyphenated Format 61874-250

Supplemental Identifiers

RxCUI
1667660 1667666 1667668 1667670 1667672 1667674 1667676 1667678 1741746 1741747 2729792 2729794 2729796 2729798
UPC
0361874275308 0361874250305
UNII
F6RJL8B278
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vraylar (source: ndc)
Generic Name cariprazine (source: ndc)
Application Number NDA204370 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-250-30)
source: ndc

Packages (1)

61874-250-30 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-250-30)

Ingredients (1)

cariprazine (.5 mg/1)

Linked Drug Pages (1)

Vraylar ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "db2154b0-f0c7-403c-95fd-794666e79e30", "openfda": {"nui": ["N0000175430"], "upc": ["0361874275308", "0361874250305"], "unii": ["F6RJL8B278"], "rxcui": ["1667660", "1667666", "1667668", "1667670", "1667672", "1667674", "1667676", "1667678", "1741746", "1741747", "2729792", "2729794", "2729796", "2729798"], "spl_set_id": ["4b5f7c65-aa2d-452a-b3db-bc85c06ff12f"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-250-30)", "package_ndc": "61874-250-30", "marketing_start_date": "20251218"}], "brand_name": "Vraylar", "product_id": "61874-250_db2154b0-f0c7-403c-95fd-794666e79e30", "dosage_form": "CAPSULE, GELATIN COATED", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "61874-250", "generic_name": "cariprazine", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vraylar", "active_ingredients": [{"name": "CARIPRAZINE", "strength": ".5 mg/1"}], "application_number": "NDA204370", "marketing_category": "NDA", "marketing_start_date": "20251218", "listing_expiration_date": "20261231"}